Short answer

Focus genetic research and clinical applications on genes identified as having low tolerance to inactivation, as these are more likely to be functionally significant and disease-relevant.

Field: User-Centred Design
Source: Nature (2020)
Method: Large-scale genetic sequencing data aggregation and analysis.
Sample: 141,456 humans (125,748 exomes and 15,708 genomes)
Evidence: Strong effect

Genes crucial for organism function are depleted of inactivating genetic variants in natural populations, allowing for classification of genes by their tolerance to inactivation. This user-centred design research insight is drawn from a 2020 study published in Nature. Using Large-scale genetic sequencing data aggregation and analysis. with 141,456 humans (125,748 exomes and 15,708 genomes), researchers explored how this design variable affects real-world outcomes. The key design takeaway: Focus genetic research and clinical applications on genes identified as having low tolerance to inactivation, as these are more likely to be functionally significant and disease-relevant.

Study

User-Centred DesignHigh ImpactStrong effect

Genetic constraint spectrum improves disease gene discovery accuracy

Genes crucial for organism function are depleted of inactivating genetic variants in natural populations, allowing for classification of genes by their tolerance to inactivation.

Nature · 2020

Key Findings

01443,769 high-confidence predicted loss-of-function variants were identified after filtering for artifacts.
02Human protein-coding genes can be classified along a spectrum of tolerance to inactivation.
03This classification improves the power of gene discovery for both common and rare diseases.

Application

Design takeaway

Focus genetic research and clinical applications on genes identified as having low tolerance to inactivation, as these are more likely to be functionally significant and disease-relevant.

How to apply

When designing genetic screening panels or drug targets for a specific disease, consult the gnomAD constraint data to prioritize genes with low tolerance to inactivation, increasing the likelihood of identifying clinically relevant targets.

Project actions

01When researching a genetic disease for a project, look up the 'constraint score' or 'pLI score' (probability of being loss-of-function intolerant) for candidate genes in gnomAD. Genes with high constraint are stronger candidates.
02Consider how this concept of gene constraint could be applied to other biological systems or even non-biological systems where 'critical components' are less tolerant to disruption.

Method & Evidence

AimTo aggregate human sequencing data to identify high-confidence loss-of-function variants and classify human protein-coding genes along a spectrum of tolerance to inactivation.

MethodLarge-scale genetic sequencing data aggregation and analysis.

ProcedureResearchers aggregated 125,748 exomes and 15,708 genomes into the Genome Aggregation Database (gnomAD), filtered for high-confidence predicted loss-of-function variants, and used an improved model of human mutation rates to classify genes by their tolerance to inactivation.

Sample141,456 humans (125,748 exomes and 15,708 genomes)

ContextHuman genetics and disease research.

Variables

IVPresence/absence and frequency of predicted loss-of-function variants in genes.

DVGene classification along a spectrum of tolerance to inactivation; power of gene discovery for diseases.

CVImproved model of human mutation rates, filtering for sequencing and annotation errors.

Strengths & Limitations

Strengths

+Extremely large sample size (141,456 humans) providing high statistical power.
+Rigorous filtering of variants to ensure high confidence.
+Validation of findings using data from model organisms and engineered human cells.

Limitations

The complexity of genetic data analysis and the need for very large datasets make direct replication challenging for student projects. The interpretation of 'loss-of-function' can be nuanced.

Reliability & validity

The study's reliability is high due to the massive dataset and rigorous filtering. Validity is supported by the biological plausibility of gene constraint and validation against external data sources.

Think critically

How might the definition of 'loss-of-function' evolve with new biological understanding, and how would this impact the gene constraint spectrum?

Design Principles

"Constraint-guided prioritization."

Understanding which genes are essential for human function helps us pinpoint the genetic causes of diseases more effectively. This knowledge can accelerate the development of diagnostics and therapies by focusing research on genes that truly impact health.

What This Means for Your Design

This study shows that if a gene is really important for a person to function, it's rare to find people with a 'broken' version of that gene. By looking at how often genes are 'broken' in a large group of people, we can figure out which genes are super important and which ones aren't. This helps us find genes that cause diseases much better.

How to use in your project

1.When designing an information architecture for a genetic database, consider including gene constraint metrics (e.g., pLI, o/e scores) as a primary filter or sorting option, allowing users to quickly identify highly constrained genes relevant to disease research.

Add to My Project

Quick Cite

Paragraph starter

Karczewski et al. (2020) demonstrated that classifying human protein-coding genes by their tolerance to inactivation, derived from large-scale human sequencing data, significantly improves the power of gene discovery for both common and rare diseases.

Source

Nature

The mutational constraint spectrum quantified from variation in 141,456 humans

journal · 2020

View source

Questions About This Research

What does the research say about genetic constraint spectrum improves disease gene discovery accuracy?: Focus genetic research and clinical applications on genes identified as having low tolerance to inactivation, as these are more likely to be functionally significant and disease-relevant. Evidence: Nature (2020).
Why does "Genetic constraint spectrum improves disease gene discovery accuracy" matter for design?: Understanding which genes are essential for human function helps us pinpoint the genetic causes of diseases more effectively. This knowledge can accelerate the development of diagnostics and therapies by focusing research on genes that truly impact health.
How can designers apply this research?: Focus genetic research and clinical applications on genes identified as having low tolerance to inactivation, as these are more likely to be functionally significant and disease-relevant.
What were the main findings?: 443,769 high-confidence predicted loss-of-function variants were identified after filtering for artifacts.. Human protein-coding genes can be classified along a spectrum of tolerance to inactivation.. This classification improves the power of gene discovery for both common and rare diseases.
What research method was used?: Large-scale genetic sequencing data aggregation and analysis. with 141,456 humans (125,748 exomes and 15,708 genomes).
How strong is the evidence?: Evidence strength is rated Strong effect, based on a 2020 journal from Nature.
What should I do differently in my next project?: When designing genetic screening panels or drug targets for a specific disease, consult the gnomAD constraint data to prioritize genes with low tolerance to inactivation, increasing the likelihood of identifying clinically relevant targets.
What are the limitations?: The study relies on predicted loss-of-function variants, which, despite filtering, may still contain some annotation errors. The model of human mutation rates, while improved, is still a model and may not perfectly reflect biological reality.